DFGX | DGCB | DFGX / DGCB | |
Gain YTD | 0.678 | 1.057 | 64% |
Net Assets | 849M | 572M | 148% |
Total Expense Ratio | 0.20 | 0.20 | 100% |
Turnover | 48.00 | 17.00 | 282% |
Yield | 4.01 | 4.28 | 94% |
Fund Existence | 2 years | 2 years | - |
DFGX | DGCB | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago53% | 2 days ago71% |
Momentum ODDS (%) | 2 days ago38% | 2 days ago57% |
MACD ODDS (%) | 2 days ago21% | 2 days ago67% |
TrendWeek ODDS (%) | 2 days ago33% | 2 days ago40% |
TrendMonth ODDS (%) | 2 days ago48% | 2 days ago63% |
Advances ODDS (%) | 6 days ago61% | 6 days ago66% |
Declines ODDS (%) | 4 days ago30% | 4 days ago32% |
BollingerBands ODDS (%) | 2 days ago80% | 2 days ago75% |
Aroon ODDS (%) | 2 days ago51% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XPH | 39.87 | 0.27 | +0.68% |
SPDR® S&P Pharmaceuticals ETF | |||
MEM | 30.91 | N/A | N/A |
Matthews Emerging Markets Eq Actv ETF | |||
OCTW | 35.86 | N/A | N/A |
AllianzIM US Large Cap Buffer20 Oct ETF | |||
FTHI | 21.82 | -0.08 | -0.37% |
First Trust BuyWrite Income ETF | |||
VIG | 194.33 | -1.27 | -0.65% |
Vanguard Dividend Appreciation ETF |